Photomed Laser Surg. 2012 Dec;30(12):681–2. doi: 10.1089/pho.2012.9881. Epub 2012 Nov 9.
No abstract available.
Read more
Category: biotech/medical – Page 2,214
Low-level laser therapy (LLLT) has been used in several in vitro experiments in order to stimulate cell proliferation. Cells such as fibroblasts, keratinocytes, lymphocytes, and osteoblasts have shown increased proliferation when submitted to laser irradiation, although little is known about the effects of LLLT on stem cells. This study aims to assess, through a systematic literature review, the effects of LLLT on the in vitro proliferation of mesenchymal stem cells. Using six different terms, we conducted an electronic search in PubMed/Medline database for articles published in the last twelve years. From 463 references obtained, only 19 papers met the search criteria and were included in this review. The analysis of the papers showed a concentration of experiments using LLLT on stem cells derived from bone marrow, dental pulp, periodontal ligament, and adipose tissue. Several protocols were used to irradiate the cells, with variations on wavelength, power density, radiation time, and state of light polarization. Most studies demonstrated an increase in the proliferation rate of the irradiated cells. It can be concluded that the laser therapy positively influences the in vitro proliferation of stem cells studied, being necessary to carry out further experiments on other cell types and to uniform the methodological designs.
Read more
Scientists from the University of Adelaide’s Research Centre for Infectious Diseases have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections, the world’s most deadly respiratory diseases.
The researchers say a single vaccination—combining vaccines from the new class of vaccines they are developing—will overcome the limitations of current influenza and pneumococcal vaccines used around the world.
Published today in the prestigious journal Nature Microbiology, they have shown that the new Influenza A virus vaccine under development (based on inactivated whole influenza virus) induces enhanced cross-protective immunity to different influenza strains, when it is co-administrated with the new class of pneumococcal vaccine.
Read more
Is it me? Or am I the only one who wishes George Church was not so secretive? https://www.nextbigfuture.com/2019/05/rejuvenate-bio-using-g…dogs.html?
Harvard Genetics Giant Geroge Church and Noah Davidsohn, a former postdoc in his lab, have engaged in a secretive antiaging venture called Rejuvenate Bio. They are making old dogs new. They have conducted gene therapy on beagles and are currently advertising for Cavalier King Charles spaniels to use gene therapy to fix their hearts.
They have identified many other targets for gene-based interventions, studying a database of aging-related genes.
Most of the work was done in mice, where they have extended the life of mice by a factor of two. Nextbigfuture notes that this would mean mice would live 6 years with treatment instead of 3 years.
Read more
With the power to turn themselves into any other cell in the body, stem cells have a future as a key treatment for a range of diseases and injuries. The problem is, they lack some of the self-defense mechanisms that other cells have, leaving them open to attack from viruses and other threats. Now, researchers from the University of Edinburgh may have found a way to switch this mechanism back on, making stem cell treatments more effective.
Read more
An innovative system to predict lung cancer could make a huge change in survival rates, with Google exploring how artificial intelligence could dramatically improve diagnosis rates. Despite advances in cancer treatment, lung cancer remains one of the most deadly diseases, not least because difficulty in identifying it among patients means it can often be too late to address.
Read more
Contact with Earthlings could even be deadly for Martians — and vice versa. Mars doesn’t have any microorganisms to carry disease, and so if cross contamination between Earth and Mars is controlled, Solomon explains that all infectious disease could be eliminated — meaning there should be no intimate connection between the two groups.
But all mutation isn’t bad. Every new baby on Earth is born with 60 new mutations, a number which Solomon says will jump to the thousands on Mars. By mutating, humans on Mars would gain critical, life-saving benefits to cope with the brutal planet: a different skin tone to protect from radiation, less reliance on oxygen to adapt to the thin atmosphere, denser bones to counteract calcium loss during pregnancy.
Solomon even suggests that we could use CRISPR to more purposefully design these helpful mutations.
Read more
Autism affects at least 2% of children in the United States—an estimated 1 in 59. This is challenging for both the patients and their parents or caregivers. What’s worse is that today there is no medical treatment for autism. That is in large part because we still don’t fully understand how autism develops and alters normal brain function.
One of the main reasons it is hard to decipher the processes that cause the disease is that it is highly variable. So how do we understand how autism changes the brain?
Using a new technology called single-nucleus RNA sequencing, we analyzed the chemistry inside specific brain cells from both healthy people and those with autism and identified dramatic differences that may cause this disease. These autism-specific differences could provide valuable new targets for drug development.
Read more